Skip to main content
AmigoFish

Ep. 381 - FIH urgency in the U.S. Plus: federated learning, biotech IPOs

From BioCentury This Week · · 31 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Pressure is on FDA, policymakers and academic centers in the U.S. to respond to challenges from China, Australia, and beyond to run first in human trials (https://www.biocentury.com/article/660354) faster and more efficiently. On the latest BioCentury This Week podcast, BioCentury’s analysts discuss how stakeholders in the U.S. are responding to the challenge. The analysts also discuss the next frontiers of federated learning in drug discovery and the latest crop of biotech IPOs (https://www.biocentury.com/article/660407) on NASDAQ, which raised over $1.2B in strong IPO run last week.

View full story: https://www.biocentury.com/article/660433

#ClinicalTrials #BiopharmaPolicy #DrugDevelopment #BiotechIPO #FederatedLearning

00:00- Introduction 01:15 - Academic Centers 10:42 - Policy Picture 15:48 - Grand Rounds Europe Highlights 18:01 - Federated Learning 28:15 - NASDAQ IPOs

To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com.

Reach us by sending a text (https://www.buzzsprout.com/1035190/fan_mail/new)

Back to BioCentury This Week · Report a problem